Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
47.86
-0.13 (-0.27%)
At close: Dec 5, 2025, 4:00 PM EST
47.98
+0.12 (0.25%)
After-hours: Dec 5, 2025, 7:59 PM EST

Novo Nordisk Revenue by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes
33.25B 33.03B 32.24B 30.91B 30.07B 28.47B 27.06B 25.14B
Diabetes Growth
10.57% 16.05% 19.11% 22.93% 24.59% 23.92% 24.31% 21.21%
Obesity
12.33B 11.32B 10.16B 8.58B 7.55B 6.99B 6.50B 5.60B
Obesity Growth
63.15% 61.82% 56.48% 53.16% 73.14% 110.41% 146.87% 159.42%
Rare Disease
3.09B 2.94B 2.91B 2.73B 2.63B 2.65B 2.68B 2.72B
Rare Disease Growth
17.73% 11.21% 8.60% 0.34% -9.75% -14.09% -16.45% -14.49%

Operating Income by Segment
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
Diabetes and Obesity Care
21.95B 21.02B 19.93B 18.36B 17.31B 16.64B 15.54B 14.13B
Diabetes and Obesity Care Growth
26.80% 26.31% 28.20% 29.95% 35.29% 41.90% 47.82% 45.45%
Rare Disease
328.26M 83.63M 96.73M 103.13M 78.63M 426.71M 460.41M 361.81M
Rare Disease Growth
317.46% -80.40% -78.99% -71.50% -87.86% -50.18% -60.20% -74.47%

Revenue by Geography
Period Ending Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
North America
28.90B 28.58B 27.80B 25.81B 24.63B 22.87B 21.32B 18.83B
North America Growth
17.33% 24.96% 30.41% 37.09% 44.35% 46.01% 49.97% 42.69%
International
19.77B 18.71B 17.51B 16.41B 15.62B 15.23B 14.92B 14.64B
International Growth
26.54% 22.84% 17.36% 12.08% 8.89% 11.10% 11.40% 13.54%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.